Xiangjun Du
Impact in
- Modeling and Simulation top 0.2%
- COVID-19 epidemiological studies
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Epidemiology 31
- Influenza Virus Research Studies 27
- Data-Driven Disease Surveillance 4
-
- COVID-19 epidemiological studies 11
- Co-authors
- Chi Zhang (4 shared papers)Andrew J. Tatem (2 shared papers)Nick Ruktanonchai (2 shared papers)Olivia Prosper (2 shared papers)Shengjie Lai (2 shared papers)Jessica Floyd (2 shared papers)Liangcai Zhou (1 shared paper)Mauricio Santillana (1 shared paper)
- Journals
- Emerging Microbes & Infections (3 papers)Viruses (3 papers)Briefings in Bioinformatics (3 papers)Nature Communications (3 papers)Frontiers in Immunology (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiangjun Du
58 papers receiving 2.8k citations
Xiangjun Du's Hit Papers
Peers
Comparison fields: 5 of 139
- Modeling and Simulation 770
- Infectious Diseases 696
- General Dentistry 11
- Epidemiology 550
- Transportation 81
Countries citing papers authored by Xiangjun Du
This map shows the geographic impact of Xiangjun Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangjun Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangjun Du more than expected).
Fields of papers citing papers by Xiangjun Du
This network shows the impact of papers produced by Xiangjun Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangjun Du. The network helps show where Xiangjun Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiangjun Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of non-pharmaceutical interventions to contain COVID-19 in China Hit paper breakdown → | 2020 | 1011 |
| 2 | 2020 | 815 | |
| 3 | 2012 | 96 | |
| 4 | 2020 | 83 | |
| 5 | 2017 | 54 | |
| 6 | 2021 | 54 | |
| 7 | 2013 | 48 | |
| 8 | 2015 | 48 | |
| 9 | 2020 | 44 | |
| 10 | 2021 | 43 | |
| 11 | 2014 | 40 | |
| 12 | 2021 | 38 | |
| 13 | 2020 | 36 | |
| 14 | 2021 | 30 | |
| 15 | 2010 | 26 | |
| 16 | 2022 | 25 | |
| 17 | 2020 | 22 | |
| 18 | 2022 | 22 | |
| 19 | 2024 | 19 | |
| 20 | 2021 | 16 |
About Xiangjun Du
Xiangjun Du is a scholar working on Epidemiology, Modeling and Simulation, Infectious Diseases, Molecular Biology and Genetics, having authored 64 papers that have together received 2.8k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (27 papers), COVID-19 epidemiological studies (11 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Data-Driven Disease Surveillance (4 papers), vaccines and immunoinformatics approaches (3 papers), RNA and protein synthesis mechanisms (2 papers), Genomics and Chromatin Dynamics (2 papers) and Mosquito-borne diseases and control (2 papers). The work is most often cited by research in Modeling and Simulation (770 citations), Infectious Diseases (696 citations), General Dentistry (11 citations), Epidemiology (550 citations) and Transportation (81 citations). Xiangjun Du has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Chi Zhang, Andrew J. Tatem, Nick Ruktanonchai, Olivia Prosper, Shengjie Lai, Jessica Floyd, Liangcai Zhou, Mauricio Santillana, Amy Wesolowski and Wei Ping Luo. Their work appears in journals such as Emerging Microbes & Infections, Viruses, Briefings in Bioinformatics, Nature Communications and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.